EMEA-000816-PIP02-10-M03

Table of contents

Key facts

Invented name
Izinova (and associated names)
Active substance
  • magnesium sulfate heptahydrate (BLI800)
  • Sodium sulphate anhydrou
  • potassium sulfate
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0159/2022
PIP number
EMEA-000816-PIP02-10-M03
Pharmaceutical form(s)
Concentrate for oral solution
Condition(s) / indication(s)
Diagnostic of organic and/or functional bowel diseases
Route(s) of administration
Oral use
Contact for public enquiries
IPSEN Consumer Healthcare

Email: ch_ra@ipsen.com
Tel. +33 158335500

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating